Comparison

My DOTmed vs Pharmabid

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

My DOTmed

This platform connects buyers and sellers of medical equipment, parts, and services. It features a vast inventory of over 700,000 listings daily, facilitating transactions in the healthcare industry.

Highlights
  • Medical equipment trading
  • Parts and services listings
  • Extensive daily inventory
  • Public trading platform
  • Global reach
Features
Read full description

DOTmed.com is the world's leading public trading platform for buying and selling medical equipment, parts and services -- we feature more than 700,000 listings on any given day.

About

Pharmabid

This platform allows licensed wholesalers, distributors, and warehousing chains to purchase pharmaceutical products directly from manufacturers. It offers access to short-dated, overstocked, or validation batch items. Buyers must have an established account in good standing with the specific manufacturer.

Highlights
  • Direct manufacturer purchasing
  • Access to special stock
  • Requires valid state license
  • Account in good standing needed
  • Order entry platform
Features
Read full description

Pharmabid is an order entry platform utilized to purchase pharmaceutical product directly from the manufacturer. Products sold on this site may be short dated, overstocked, or validation batches which are sold to buyers. To participate in Pharmabid®, a buyer must have a valid state license as a wholesaler, distributor, or warehousing chain. Note: Buyers must have an account open, and in good standing with the manufacturer whose product they are purchasing.

Screenshots

My DOTmed4 screens
Pharmabid4 screens

Verdict

The call

The clearest difference is rating: Pharmabid at 5.0 against My DOTmed's 3.3. On price, ratings volume, update cadence and ads there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

Pharmabid holds the better App Store score, 5.0 against 3.3. Both are backed by a comparable volume of ratings — 3 and 2 respectively.

UpkeepUpdate frequency

My DOTmed ships an update every 3 months, Pharmabid every 2 months. The most recent releases landed on October 6, 2026 and October 14, 2026 respectively.

Scorecard1 real difference · 9 level
My DOTmed versus Pharmabid: the parameters behind the verdict, then further details
ParameterMy DOTmedPharmabid
PriceFreeFree
Rating3.3 (3 ratings)5.0 (2 ratings) — better
Positive reviews42.9% of reviews—
Number of ratings3 — better2
Update frequencyEvery 3 monthsEvery 2 months — better
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS14.0 — better15.0
Further details — not scored
Size33 MB24 MB
Age rating4+17+
DeveloperDOTmed.com, Inc.PHARMABID, LLC

Customer experience

My DOTmed

All ratings3 ratings
Positive33.3%
Neutral33.3%
Negative33.3%
Written reviews7 reviews
Positive42.9%
Neutral28.6%
Negative28.6%

Pharmabid

All ratings2 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

My DOTmed

No in-app purchases

None

Pharmabid

No in-app purchases

Questions

Is My DOTmed free?
My DOTmed is free to download, with no in-app purchases.
Is Pharmabid free?
Pharmabid is free to download, with no in-app purchases.
Which has better reviews, My DOTmed or Pharmabid?
Pharmabid is rated higher. My DOTmed averages 3.3 out of 5 from 3 ratings, while Pharmabid averages 5.0 from 2 ratings.
Do My DOTmed or Pharmabid have ads?
Neither My DOTmed nor Pharmabid shows ads.
Which is updated more often, My DOTmed or Pharmabid?
My DOTmed ships an update every 3 months, and Pharmabid every 2 months. Most recently, My DOTmed was updated on October 6, 2026 and Pharmabid on October 14, 2026.

Other comparisons